Alkermes (ALKS) Financials

$27.94 +0.40 (+1.45%)

Closing price 04:00 PM Eastern

Extended Trading

$27.74 -0.20 (-0.70%)

As of 06:12 PM Eastern

Annual Income Statements for Alkermes

This table shows Alkermes' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-227	-208	-158	-139	-195	-110	-51	-165	364	368
Consolidated Net Income / (Loss)	-227	-208	-158	-139	-197	-111	-48	-158	356	367
Net Income / (Loss) Continuing Operations	-227	-208	-158	-139	-197	-111	76	-33	519	372
Total Pre-Tax Income	-224	-214	-143	-127	-197	-97	88	-31	422	444
Total Operating Income	-224	-209	-148	-99	-175	-112	98	-6.09	414	421
Total Gross Profit	489	614	749	918	991	860	976	894	1,410	1,312
Total Revenue	628	746	903	1,094	1,171	1,039	1,174	1,112	1,663	1,558
Operating Revenue	628	746	903	1,094	1,171	1,039	1,174	1,112	1,663	1,558
Total Cost of Revenue	139	132	155	176	180	178	197	218	253	245
Operating Cost of Revenue	139	132	155	176	180	178	197	218	253	245
Total Operating Expenses	714	822	897	1,017	1,166	973	879	900	996	892
Selling, General & Admin Expense	312	374	422	526	599	539	550	591	690	645
Research & Development Expense	344	387	413	425	513	395	291	273	271	245
Amortization Expense	58	61	62	65	40	39	38	36	36	1.10
Total Other Income / (Expense), net	0.30	-5.72	4.63	-28	-22	16	-10	-25	7.40	23
Interest Expense	13	15	12	15	14	8.66	11	13	23	23
Interest & Investment Income	3.33	3.75	4.65	9.24	14	6.96	2.41	7.63	31	42
Other Income / (Expense), net	10	5.42	12	-22	-22	18	-1.21	-20	-0.43	3.24
Income Tax Expense	3.16	-5.94	15	12	-0.44	14	11	2.02	-98	72
Net Income / (Loss) Discontinued Operations	-	-	-	-	-	-	-125	-125	-163	-5.07
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	-	-0.52	0.52	-0.51	-1.46	-0.47	2.37	7.17	-7.78	-1.14
Basic Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.14	$2.22
Weighted Average Basic Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	163.74M	166.22M	165.39M
Diluted Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.29)	($0.97)	$2.10	$2.17
Weighted Average Diluted Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	164.75M	163.74M	169.73M	169.20M
Weighted Average Basic & Diluted Shares Outstanding	149.21M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	164.39M	167.08M	162.61M

This table shows Alkermes' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-66	-26	-39	238	49	116	36	91	96	144
Consolidated Net Income / (Loss)	-64	-28	-42	237	48	113	37	91	92	147
Net Income / (Loss) Continuing Operations	-64	97	-12	279	92	161	39	95	93	146
Total Pre-Tax Income	-67	114	-11	282	93	58	47	117	110	170
Total Operating Income	-61	116	-11	281	89	55	43	110	105	163
Total Gross Profit	202	251	229	554	319	307	292	338	315	368
Total Revenue	252	305	288	617	381	377	350	399	378	430
Operating Revenue	252	305	288	617	381	377	350	399	378	430
Total Cost of Revenue	51	54	58	63	61	70	59	61	63	62
Operating Cost of Revenue	51	54	58	63	61	70	59	61	63	62
Total Operating Expenses	262	135	240	273	230	253	248	228	210	205
Selling, General & Admin Expense	153	143	168	196	156	170	180	168	150	147
Research & Development Expense	100	-17	64	68	65	74	68	60	60	58
Amortization Expense	9.17	9.17	8.80	8.90	9.00	9.00	1.06	0.01	0.01	0.01
Total Other Income / (Expense), net	-6.73	-1.11	-0.36	0.56	3.51	3.69	3.60	6.84	5.47	7.20
Interest Expense	3.55	4.77	5.29	5.68	6.01	6.05	5.98	5.95	6.00	4.65
Interest & Investment Income	2.24	3.92	4.97	6.77	9.37	9.75	9.40	11	11	11
Other Income / (Expense), net	-5.41	-0.26	-0.04	-0.53	0.15	-0.01	0.18	2.05	0.56	0.45
Income Tax Expense	-3.39	18	0.72	2.73	1.15	-102	7.96	22	17	24
Net Income / (Loss) Discontinued Operations	-	-	-30	-42	-44	-48	-2.12	-3.30	-0.41	0.77
Other Adjustments to Net Income / (Loss) Attributable to Common Shareholders)	2.35	-1.95	-2.76	-0.69	-1.36	-2.96	0.49	-0.01	-4.02	2.39
Basic Earnings per Share	($0.39)	($0.18)	($0.25)	$1.43	$0.29	$0.67	$0.22	$0.54	$0.57	$0.89
Weighted Average Basic Shares Outstanding	164.28M	163.74M	165.09M	166.28M	166.61M	166.22M	167.98M	168.32M	163.37M	165.39M
Diluted Earnings per Share	($0.39)	($0.18)	($0.25)	$1.38	$0.28	$0.69	$0.21	$0.53	$0.55	$0.88
Weighted Average Diluted Shares Outstanding	164.28M	163.74M	165.09M	171.55M	171.90M	169.73M	172.98M	170.98M	167.03M	169.20M
Weighted Average Basic & Diluted Shares Outstanding	164.31M	164.39M	166.12M	166.56M	166.88M	167.08M	169.22M	164.67M	161.80M	162.61M

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	-43	5.27	4.92	75	-63	69	65	-45	165	-166
Net Cash From Operating Activities	-40	-64	19	99	72	83	102	21	401	439
Net Cash From Continuing Operating Activities	-40	-64	19	99	72	83	102	21	401	439
Net Income / (Loss) Continuing Operations	-227	-208	-158	-139	-197	-111	-48	-158	356	367
Consolidated Net Income / (Loss)	-227	-208	-158	-139	-197	-111	-48	-158	356	367
Depreciation Expense	86	94	99	104	80	82	79	78	75	29
Non-Cash Adjustments To Reconcile Net Income	55	95	105	115	104	87	115	119	127	106
Changes in Operating Assets and Liabilities, net	47	-45	-26	20	85	25	-43	-18	-156	-62
Net Cash From Investing Activities	-43	127	-18	-22	-142	-11	-66	-65	53	-111
Net Cash From Continuing Investing Activities	-43	127	-18	-22	-142	-11	-66	-65	53	-111
Purchase of Property, Plant & Equipment	-53	-44	-51	-69	-91	-42	-28	-38	-48	-33
Purchase of Investments	-509	-375	-432	-398	-278	-230	-340	-310	-254	-487
Sale of Property, Plant & Equipment	0.54	0.19	0.16	0.51	0.90	0.64	0.29	0.00	0.35	0.46
Divestitures	50	-	-	-	-	-	-	0.00	0.00	98
Sale and/or Maturity of Investments	468	561	464	444	225	256	295	282	356	310
Other Investing Activities, net	-	-	0.00	0.00	10	3.89	6.94	1.76	0.00	0.04
Net Cash From Financing Activities	41	-58	4.08	-1.62	6.77	-2.17	29	-1.57	-290	-494
Net Cash From Continuing Financing Activities	41	-58	4.08	-1.62	6.77	-2.17	29	-1.57	-290	-494
Repayment of Debt	-6.75	-69	-3.00	-2.88	-2.84	-2.84	-3.24	-3.00	-3.00	-292
Repurchase of Common Equity	-	-	-	-	-	-	-	0.00	0.00	-200
Issuance of Common Equity	45	20	24	21	19	8.37	25	20	17	28
Other Financing Activities, net	2.67	-9.24	-16	-20	-9.32	-7.70	-17	-18	-303	-30
Cash Interest Paid	12	12	11	13	13	8.29	6.90	14	23	23
Cash Income Taxes Paid	0.71	5.53	2.99	0.75	2.51	0.62	1.89	21	44	2.59

This table details how cash moves in and out of Alkermes' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	9.31	29	29	344	-18	-190	-37	114	-139	-105
Net Cash From Operating Activities	0.63	1.05	-21	216	100	107	21	146	82	190
Net Cash From Continuing Operating Activities	0.63	1.05	-21	216	100	107	21	146	82	190
Net Income / (Loss) Continuing Operations	-64	-28	-42	237	48	113	37	91	92	147
Consolidated Net Income / (Loss)	-64	-28	-42	237	48	113	37	91	92	147
Depreciation Expense	20	20	19	19	19	19	8.06	6.66	6.97	6.85
Non-Cash Adjustments To Reconcile Net Income	42	46	54	-14	29	58	13	41	41	10
Changes in Operating Assets and Liabilities, net	2.79	-36	-52	-27	4.24	-82	-37	6.84	-58	27
Net Cash From Investing Activities	8.90	28	73	121	-119	-21	-40	52	-109	-14
Net Cash From Continuing Investing Activities	8.90	28	73	121	-119	-21	-40	52	-109	-14
Purchase of Property, Plant & Equipment	-10	-10	-6.86	-9.71	-14	-17	-8.34	-7.11	-8.26	-9.77
Purchase of Investments	-62	-53	-24	-6.39	-156	-68	-115	-95	-187	-90
Sale of Property, Plant & Equipment	-	-	0.00	0.00	0.00	0.35	0.41	0.02	0.02	0.01
Sale and/or Maturity of Investments	81	91	104	137	51	64	82	56	86	86
Other Investing Activities, net	0.23	-	0.00	-	-	-	0.00	-	-	0.04
Net Cash From Financing Activities	-0.21	-0.27	-23	7.84	1.57	-276	-18	-83	-111	-282
Net Cash From Continuing Financing Activities	-0.21	-0.27	-23	7.84	1.57	-276	-18	-83	-111	-282
Repayment of Debt	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-0.75	-290
Repurchase of Common Equity	-	-	-	-	-	-	-	-	-116	-0.00
Issuance of Common Equity	0.86	0.78	2.87	9.13	3.11	1.65	11	2.61	5.52	8.22
Other Financing Activities, net	-0.32	-0.30	-25	-0.54	-0.80	-277	-28	-0.65	-0.29	-0.34

This table presents Alkermes' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	1,856	1,726	1,797	1,825	1,805	1,950	2,024	1,964	2,136	2,056
Total Current Assets	755	791	809	983	962	1,111	1,062	1,130	1,486	1,415
Cash & Equivalents	181	186	191	267	204	273	338	292	457	291
Short-Term Investments	354	311	242	273	331	362	199	316	316	461
Accounts Receivable	155	191	234	292	257	275	313	288	332	385
Inventories, net	38	63	93	90	102	126	150	181	186	183
Prepaid Expenses	26	39	48	53	60	61	49	41	98	91
Other Current Assets	-	-	0.00	8.23	8.39	25	13	8.93	95	4.99
Other Current Nonoperating Assets	-	-	-	-	-	-	-	2.32	0.00	0.00
Plant, Property, & Equipment, net	255	265	285	310	362	350	341	223	227	228
Total Noncurrent Assets	846	671	704	532	481	479	621	611	424	413
Long-Term Investments	264	122	157	81	79	25	229	132	40	73
Goodwill	93	93	93	93	93	93	93	83	85	84
Noncurrent Deferred & Refundable Income Taxes	41	48	99	86	97	86	82	115	196	155
Other Noncurrent Operating Assets	69	90	99	81	62	163	143	206	103	101
Total Liabilities & Shareholders' Equity	1,856	1,726	1,797	1,825	1,805	1,950	2,024	1,964	2,136	2,056
Total Liabilities	541	517	594	654	720	883	912	920	934	591
Total Current Liabilities	236	212	291	340	391	438	471	498	520	465
Short-Term Debt	66	3.00	3.00	2.84	2.84	19	3.00	3.00	3.00	0.00
Accounts Payable	169	207	286	334	373	412	208	220	241	185
Accrued Expenses	-	-	-	-	-	-	237	252	264	272
Current Deferred Revenue	1.74	1.94	1.96	3.17	6.77	-	-	-	2.73	1.25
Other Current Liabilities	-	-	-	0.00	8.47	7.51	23	17	5.75	6.17
Other Current Nonoperating Liabilities	-	-	-	-	-	-	-	5.84	4.54	0.00
Total Noncurrent Liabilities	305	305	303	314	329	444	441	422	413	125
Long-Term Debt	284	281	278	276	274	272	293	290	288	0.00
Other Noncurrent Operating Liabilities	13	17	19	28	32	53	148	119	126	125
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465
Total Preferred & Common Equity	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,314	1,209	1,203	1,171	1,085	1,067	1,113	1,044	1,203	1,465
Common Stock	2,116	2,233	2,340	2,469	2,588	2,687	2,800	2,915	2,739	2,863
Retained Earnings	-739	-948	-1,044	-1,185	-1,382	-1,493	-1,541	-1,699	-1,344	-976
Treasury Stock	-59	-73	-89	-109	-118	-126	-143	-161	-189	-419
Accumulated Other Comprehensive Income / (Loss)	-3.80	-3.27	-3.79	-3.28	-1.82	-1.35	-3.72	-11	-3.11	-1.97

This table presents Alkermes' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	1,942	1,923	2,187	2,279	2,124	2,207	2,155
Total Current Assets	1,054	1,110	1,397	1,465	1,469	1,542	1,564
Cash & Equivalents	264	321	666	648	421	535	396
Short-Term Investments	316	279	163	241	324	341	513
Accounts Receivable	257	269	334	338	316	366	367
Inventories, net	166	185	189	192	198	195	191
Prepaid Expenses	40	47	44	43	112	101	94
Other Current Assets	10	8.43	0.00	2.77	98	3.49	2.97
Other Current Nonoperating Assets	-	-	-	-	0.00	0.00	0.00
Plant, Property, & Equipment, net	326	321	324	328	225	223	225
Total Noncurrent Assets	562	492	466	487	430	442	366
Long-Term Investments	167	92	78	106	63	86	19
Goodwill	93	93	93	93	83	84	84
Noncurrent Deferred & Refundable Income Taxes	137	151	153	162	183	167	160
Other Noncurrent Operating Assets	118	126	122	114	101	104	103
Other Noncurrent Nonoperating Assets	-	-	-	-	0.00	0.00	0.00
Total Liabilities & Shareholders' Equity	1,942	1,923	2,187	2,279	2,124	2,207	2,155
Total Liabilities	899	917	907	924	869	923	863
Total Current Liabilities	470	493	487	503	459	516	454
Short-Term Debt	3.00	3.00	3.00	3.00	3.00	3.00	3.00
Accounts Payable	211	190	243	243	206	240	160
Accrued Expenses	236	282	223	238	241	263	282
Current Deferred Revenue	-	-	-	-	3.34	3.31	2.34
Other Current Liabilities	20	17	18	18	5.91	6.01	6.15
Other Current Nonoperating Liabilities	-	-	-	-	0.00	0.00	0.00
Total Noncurrent Liabilities	429	424	420	421	410	407	409
Long-Term Debt	291	290	289	288	287	286	286
Other Noncurrent Operating Liabilities	139	135	131	132	123	121	124
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,043	1,006	1,280	1,356	1,255	1,284	1,292
Total Preferred & Common Equity	1,043	1,006	1,280	1,356	1,255	1,284	1,292
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	1,043	1,006	1,280	1,356	1,255	1,284	1,292
Common Stock	2,887	2,940	2,978	3,005	2,783	2,806	2,834
Retained Earnings	-1,671	-1,741	-1,504	-1,456	-1,307	-1,215	-1,123
Treasury Stock	-161	-186	-186	-187	-218	-303	-419
Accumulated Other Comprehensive Income / (Loss)	-13	-8.13	-7.44	-6.07	-3.60	-3.59	0.43

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	1.54%	18.68%	21.15%	21.13%	7.01%	-11.29%	13.00%	-5.28%	49.61%	-6.36%
EBITDA Growth	-234.52%	15.17%	65.69%	54.25%	-584.00%	88.90%	1,449.28%	-70.24%	837.05%	-7.41%
EBIT Growth	-8,227.03%	5.06%	33.13%	11.14%	-63.48%	51.96%	201.79%	-126.64%	1,708.65%	2.46%
NOPAT Growth	-157.39%	6.97%	29.12%	32.98%	-77.02%	35.93%	208.17%	-105.01%	12,066.46%	-30.84%
Net Income Growth	-655.67%	8.24%	24.23%	11.80%	-41.14%	43.62%	56.55%	-228.57%	324.78%	3.18%
EPS Growth	-623.81%	9.21%	25.36%	12.62%	-38.89%	44.00%	58.57%	-234.48%	316.49%	3.33%
Operating Cash Flow Growth	-462.33%	-58.08%	130.08%	417.36%	-27.40%	14.94%	22.78%	-79.31%	1,807.21%	9.41%
Free Cash Flow Firm Growth	-120.04%	-116.53%	20.43%	94.79%	-531.14%	-265.07%	275.76%	-76.08%	546.49%	-1.13%
Invested Capital Growth	-9.00%	1.00%	2.24%	-7.05%	-9.91%	9.24%	-21.37%	-10.33%	18.80%	-6.49%
Revenue Q/Q Growth	-1.88%	7.25%	7.35%	3.83%	9.03%	-11.33%	3.94%	-1.75%	4.58%	3.49%
EBITDA Q/Q Growth	-1,078.83%	32.76%	47.21%	-366.03%	-5.82%	-151.00%	3,925.51%	-22.73%	-11.24%	27.23%
EBIT Q/Q Growth	-113.91%	19.82%	19.47%	-13.24%	-0.53%	-67.63%	231.37%	-117.19%	-12.80%	34.41%
NOPAT Q/Q Growth	-29.70%	17.26%	16.57%	-6.23%	-6.01%	-22.69%	294.89%	-178.74%	12.60%	-3.12%
Net Income Q/Q Growth	-78.49%	18.79%	6.71%	0.05%	2.17%	-50.68%	47.46%	-22.55%	65.68%	10.12%
EPS Q/Q Growth	-78.82%	18.34%	8.04%	-1.12%	3.85%	-55.56%	50.00%	-25.97%	70.73%	9.60%
Operating Cash Flow Q/Q Growth	-304.00%	49.18%	309.47%	32.95%	-20.37%	43.90%	-26.31%	-58.75%	35.98%	23.36%
Free Cash Flow Firm Q/Q Growth	-46.52%	-8.42%	20.00%	62.08%	-3,341.67%	-65.13%	182.44%	45.17%	2.67%	9.61%
Invested Capital Q/Q Growth	-4.33%	0.38%	-0.77%	-2.52%	1.48%	7.16%	2.49%	-2.27%	5.10%	-1.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	77.88%	82.28%	82.87%	83.88%	84.59%	82.83%	83.19%	80.39%	84.79%	84.25%
EBITDA Margin	-20.45%	-14.62%	-4.14%	-1.56%	-9.99%	-1.25%	14.93%	4.69%	29.37%	29.04%
Operating Margin	-35.70%	-27.98%	-16.37%	-9.06%	-14.99%	-10.82%	8.33%	-0.55%	24.90%	27.00%
EBIT Margin	-34.07%	-27.26%	-15.05%	-11.04%	-16.86%	-9.13%	8.22%	-2.31%	24.87%	27.21%
Profit (Net Income) Margin	-36.15%	-27.95%	-17.48%	-12.73%	-16.79%	-10.67%	-4.10%	-14.24%	21.39%	23.57%
Tax Burden Percent	101.41%	97.23%	110.24%	109.72%	99.78%	114.84%	-54.91%	508.44%	84.40%	82.72%
Interest Burden Percent	104.63%	105.48%	105.41%	105.13%	99.81%	101.79%	90.87%	121.04%	101.89%	104.69%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	12.91%	0.00%	-23.16%	16.14%
Return on Invested Capital (ROIC)	-17.29%	-16.80%	-11.71%	-8.05%	-15.56%	-10.05%	11.66%	-0.70%	80.91%	53.26%
ROIC Less NNEP Spread (ROIC-NNEP)	-1.61%	-0.89%	5.16%	13.46%	6.21%	0.91%	48.71%	32.16%	112.22%	51.12%
Return on Net Nonoperating Assets (RNNOA)	0.53%	0.28%	-1.38%	-3.69%	-1.86%	-0.25%	-16.08%	-13.98%	-49.23%	-25.74%
Return on Equity (ROE)	-16.76%	-16.52%	-13.10%	-11.74%	-17.43%	-10.30%	-4.42%	-14.68%	31.67%	27.52%
Cash Return on Invested Capital (CROIC)	-7.87%	-17.79%	-13.93%	-0.74%	-5.13%	-18.88%	35.59%	10.20%	63.72%	59.96%
Operating Return on Assets (OROA)	-11.34%	-11.35%	-7.71%	-6.67%	-10.88%	-5.05%	4.86%	-1.29%	20.18%	20.22%
Return on Assets (ROA)	-12.04%	-11.64%	-8.96%	-7.69%	-10.83%	-5.90%	-2.42%	-7.94%	17.35%	17.51%
Return on Common Equity (ROCE)	-16.76%	-16.52%	-13.10%	-11.74%	-17.43%	-10.30%	-4.42%	-14.68%	31.67%	27.52%
Return on Equity Simple (ROE_SIMPLE)	-17.28%	-17.23%	-13.13%	-11.89%	-18.11%	-10.39%	-4.33%	-15.16%	29.58%	25.06%
Net Operating Profit after Tax (NOPAT)	-157	-146	-104	-69	-123	-79	85	-4.26	510	353
NOPAT Margin	-24.99%	-19.59%	-11.46%	-6.34%	-10.49%	-7.58%	7.25%	-0.38%	30.66%	22.65%
Net Nonoperating Expense Percent (NNEP)	-15.68%	-15.90%	-16.88%	-21.51%	-21.77%	-10.96%	-37.05%	-32.86%	-31.31%	2.13%
Return On Investment Capital (ROIC_SIMPLE)	-9.43%	-9.78%	-6.98%	-4.78%	-9.01%	-5.33%	6.04%	-0.32%	34.15%	24.08%
Cost of Revenue to Revenue	22.12%	17.72%	17.13%	16.12%	15.41%	17.17%	16.81%	19.61%	15.21%	15.75%
SG&A Expenses to Revenue	49.58%	50.17%	46.67%	48.11%	51.19%	51.87%	46.83%	53.13%	41.47%	41.42%
R&D to Revenue	54.81%	51.92%	45.71%	38.88%	43.80%	37.99%	24.79%	24.53%	16.28%	15.75%
Operating Expenses to Revenue	113.58%	110.26%	99.24%	92.94%	99.58%	93.66%	74.86%	80.93%	59.89%	57.24%
Earnings before Interest and Taxes (EBIT)	-214	-203	-136	-121	-197	-95	97	-26	414	424
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-128	-109	-37	-17	-117	-13	175	52	489	452
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.43	6.49	6.50	3.64	2.75	2.77	3.14	3.82	3.85	3.18
Price to Tangible Book Value (P/TBV)	13.15	9.83	9.16	4.80	3.55	3.42	3.70	4.32	4.14	3.37
Price to Revenue (P/Rev)	17.62	10.53	8.66	3.90	2.55	2.84	2.98	3.59	2.78	2.99
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	12.73	12.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	7.85%	7.91%
Enterprise Value to Invested Capital (EV/IC)	12.28	8.60	8.41	4.72	3.54	3.31	4.71	6.15	6.00	5.98
Enterprise Value to Revenue (EV/Rev)	16.91	10.08	8.32	3.58	2.26	2.60	2.58	3.19	2.47	2.46
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	17.28	67.97	8.40	8.46
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	31.35	0.00	9.93	9.03
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	35.55	0.00	8.05	10.85
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	391.58	39.50	36.77	32.62	29.76	168.43	10.23	8.72
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	11.65	57.04	10.22	9.64
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.27	0.23	0.23	0.24	0.26	0.38	0.27	0.28	0.24	0.00
Long-Term Debt to Equity	0.22	0.23	0.23	0.24	0.25	0.37	0.26	0.28	0.24	0.00
Financial Leverage	-0.33	-0.31	-0.27	-0.27	-0.30	-0.27	-0.33	-0.43	-0.44	-0.50
Leverage Ratio	1.39	1.42	1.46	1.53	1.61	1.74	1.82	1.85	1.83	1.57
Compound Leverage Factor	1.46	1.50	1.54	1.60	1.61	1.78	1.66	2.24	1.86	1.65
Debt to Total Capital	21.03%	19.00%	18.96%	19.25%	20.34%	27.77%	21.00%	21.93%	19.47%	0.00%
Short-Term Debt to Total Capital	3.95%	0.20%	0.20%	0.20%	0.21%	1.26%	0.21%	0.22%	0.20%	0.00%
Long-Term Debt to Total Capital	17.08%	18.80%	18.76%	19.06%	20.13%	26.51%	20.79%	21.71%	19.27%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.97%	81.00%	81.04%	80.75%	79.66%	72.23%	79.00%	78.07%	80.53%	100.00%
Debt to EBITDA	-2.72	-2.60	-7.53	-16.33	-2.37	-31.59	1.69	5.62	0.60	0.00
Net Debt to EBITDA	3.49	3.08	8.27	19.92	2.88	19.23	-2.68	-8.57	-1.07	0.00
Long-Term Debt to EBITDA	-2.21	-2.58	-7.45	-16.16	-2.34	-30.16	1.67	5.57	0.59	0.00
Debt to NOPAT	-2.23	-1.94	-2.72	-4.03	-2.26	-5.21	3.47	-68.81	0.57	0.00
Net Debt to NOPAT	2.86	2.30	2.99	4.91	2.75	3.17	-5.52	104.83	-1.02	0.00
Long-Term Debt to NOPAT	-1.81	-1.92	-2.69	-3.98	-2.23	-4.98	3.44	-68.10	0.56	0.00
Altman Z-Score	12.01	8.79	7.68	3.81	2.09	1.72	2.32	2.30	4.05	6.06
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.20	3.73	2.78	2.89	2.46	2.54	2.25	2.27	2.86	3.04
Quick Ratio	2.92	3.25	2.29	2.45	2.03	2.08	1.80	1.80	2.13	2.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-71	-155	-123	-6.42	-40	-148	260	62	402	397
Operating Cash Flow to CapEx	-77.11%	-146.80%	37.53%	144.04%	80.05%	199.25%	366.77%	55.01%	841.52%	1,329.75%
Free Cash Flow to Firm to Interest Expense	-5.39	-10.39	-10.25	-0.42	-2.98	-17.07	23.16	4.77	17.44	17.59
Operating Cash Flow to Interest Expense	-3.05	-4.29	1.60	6.43	5.30	9.57	9.07	1.61	17.43	19.45
Operating Cash Flow Less CapEx to Interest Expense	-7.00	-7.20	-2.66	1.97	-1.32	4.77	6.59	-1.32	15.36	17.99
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.33	0.42	0.51	0.60	0.65	0.55	0.59	0.56	0.81	0.74
Accounts Receivable Turnover	4.09	4.30	4.25	4.16	4.26	3.90	3.99	3.70	5.36	4.34
Inventory Turnover	3.10	2.61	1.98	1.92	1.88	1.57	1.43	1.31	1.38	1.33
Fixed Asset Turnover	2.41	2.87	3.29	3.68	3.48	2.92	3.40	3.94	7.40	6.85
Accounts Payable Turnover	0.96	0.70	0.63	0.57	0.51	0.45	0.64	1.02	1.10	1.15
Days Sales Outstanding (DSO)	89.18	84.82	85.80	87.69	85.61	93.51	91.48	98.68	68.07	84.01
Days Inventory Outstanding (DIO)	117.87	140.08	184.30	189.79	194.25	232.88	255.33	277.64	265.29	274.71
Days Payable Outstanding (DPO)	380.78	519.08	581.67	641.29	715.09	803.63	574.04	358.68	332.24	316.82
Cash Conversion Cycle (CCC)	-173.73	-294.18	-311.58	-363.81	-435.22	-477.24	-227.23	17.65	1.12	41.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	865	874	894	831	748	817	643	576	685	640
Invested Capital Turnover	0.69	0.86	1.02	1.27	1.48	1.33	1.61	1.82	2.64	2.35
Increase / (Decrease) in Invested Capital	-86	8.61	20	-63	-82	69	-175	-66	108	-44
Enterprise Value (EV)	10,624	7,516	7,514	3,922	2,650	2,702	3,027	3,544	4,107	3,829
Market Capitalization	11,073	7,852	7,824	4,263	2,987	2,952	3,497	3,991	4,629	4,653
Book Value per Share	$8.76	$7.96	$7.82	$7.54	$6.89	$6.70	$6.88	$6.35	$7.21	$9.05
Tangible Book Value per Share	$5.61	$5.25	$5.55	$5.71	$5.34	$5.42	$5.85	$5.62	$6.70	$8.54
Total Capital	1,664	1,493	1,484	1,451	1,363	1,477	1,408	1,337	1,493	1,465
Total Debt	350	284	281	279	277	410	296	293	291	0.00
Total Long-Term Debt	284	281	278	276	274	392	293	290	288	0.00
Net Debt	-449	-335	-309	-341	-337	-250	-470	-447	-523	-825
Capital Expenditures (CapEx)	52	43	51	69	90	42	28	38	48	33
Debt-free, Cash-free Net Working Capital (DFCFNWC)	50	84	87	107	39	56	58	27	195	198
Debt-free Net Working Capital (DFNWC)	584	582	521	646	574	691	594	636	968	950
Net Working Capital (NWC)	519	579	518	643	571	673	591	633	965	950
Net Nonoperating Expense (NNE)	70	62	54	70	74	32	133	154	154	-14
Net Nonoperating Obligations (NNO)	-449	-335	-309	-341	-337	-250	-470	-468	-518	-825
Total Depreciation and Amortization (D&A)	86	94	99	104	80	82	79	78	75	29
Debt-free, Cash-free Net Working Capital to Revenue	7.91%	11.33%	9.65%	9.78%	3.31%	5.42%	4.91%	2.44%	11.71%	12.74%
Debt-free Net Working Capital to Revenue	93.02%	78.01%	57.64%	59.06%	48.99%	66.55%	50.60%	57.17%	58.21%	61.00%
Net Working Capital to Revenue	82.56%	77.60%	57.31%	58.80%	48.75%	64.76%	50.34%	56.90%	58.03%	61.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.14	$2.22
Adjusted Weighted Average Basic Shares Outstanding	149.21M	152.55M	156.14M	156.04M	157.79M	159.24M	161.97M	163.54M	166.22M	165.39M
Adjusted Diluted Earnings per Share	($1.52)	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	($0.97)	$2.10	$2.17
Adjusted Weighted Average Diluted Shares Outstanding	149.21M	152.55M	156.14M	156.04M	157.79M	159.24M	161.97M	163.54M	169.73M	169.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	($1.38)	($1.03)	($0.90)	($1.25)	($0.70)	($0.30)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	150.74M	151.48M	153.42M	155.11M	157.05M	158.80M	160.94M	164.39M	167.08M	162.61M
Normalized Net Operating Profit after Tax (NOPAT)	-157	-146	-104	-69	-113	-79	85	-4.26	290	353
Normalized NOPAT Margin	-24.99%	-19.59%	-11.46%	-6.34%	-9.69%	-7.58%	7.25%	-0.38%	17.43%	22.65%
Pre Tax Income Margin	-35.65%	-28.75%	-15.86%	-11.60%	-16.83%	-9.29%	7.47%	-2.80%	25.34%	28.49%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-16.16	-13.65	-11.32	-7.82	-14.52	-10.95	8.60	-1.97	17.96	18.77
NOPAT to Interest Expense	-11.85	-9.81	-8.62	-4.50	-9.03	-9.09	7.59	-0.33	22.15	15.62
EBIT Less CapEx to Interest Expense	-20.11	-16.57	-15.58	-12.29	-21.14	-15.75	6.13	-4.91	15.89	17.31
NOPAT Less CapEx to Interest Expense	-15.80	-12.73	-12.88	-8.96	-15.65	-13.89	5.12	-3.26	20.07	14.16
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	54.56%

This table displays calculated financial ratios and metrics derived from Alkermes' official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-14.21%	-6.10%	3.25%	123.52%	50.95%	23.89%	21.83%	-35.35%	-0.73%	13.91%
EBITDA Growth	-797.74%	-10.20%	132.06%	2,520.11%	332.48%	-45.81%	569.18%	-60.44%	3.96%	132.34%
EBIT Growth	-168.89%	-10.74%	74.52%	983.48%	235.26%	-52.64%	494.98%	-60.13%	17.88%	198.67%
NOPAT Growth	-208.46%	-23.34%	58.73%	1,254.84%	307.51%	53.80%	568.16%	-68.01%	0.12%	-7.21%
Net Income Growth	-120.69%	-3,336.43%	-16.55%	886.65%	174.65%	499.16%	188.01%	-61.46%	93.44%	29.90%
EPS Growth	-116.67%	-1,000.00%	-13.64%	866.67%	171.79%	483.33%	184.00%	-61.59%	96.43%	27.54%
Operating Cash Flow Growth	-99.25%	-96.62%	-198.27%	9,454.29%	15,853.28%	10,142.31%	199.09%	-32.30%	-18.17%	77.55%
Free Cash Flow Firm Growth	-104.15%	-45.68%	-101.63%	172.10%	621.28%	-74.38%	-6,322.67%	-37.68%	227.75%	337.28%
Invested Capital Growth	-5.96%	-10.33%	-1.01%	7.84%	10.47%	18.80%	21.69%	-8.16%	0.27%	-6.49%
Revenue Q/Q Growth	-8.64%	20.73%	-5.61%	114.68%	-38.30%	-0.91%	-7.18%	13.92%	-5.26%	13.71%
EBITDA Q/Q Growth	-275.08%	390.61%	-94.29%	3,791.41%	-63.97%	-32.26%	-29.54%	130.07%	-5.32%	51.38%
EBIT Q/Q Growth	-107.87%	274.61%	-109.55%	2,649.67%	-68.18%	-38.86%	-20.38%	157.38%	-5.92%	54.91%
NOPAT Q/Q Growth	-75.99%	330.39%	-107.85%	3,726.72%	-68.38%	70.75%	-76.09%	147.84%	-1.04%	58.25%
Net Income Q/Q Growth	-112.28%	55.84%	-48.10%	666.53%	-79.85%	136.15%	-67.35%	148.07%	1.12%	58.59%
EPS Q/Q Growth	-116.67%	53.85%	-38.89%	652.00%	-79.71%	146.43%	-69.57%	152.38%	3.77%	60.00%
Operating Cash Flow Q/Q Growth	127.10%	67.52%	-2,134.58%	1,112.63%	-53.78%	7.55%	-80.32%	591.82%	-44.13%	133.36%
Free Cash Flow Firm Q/Q Growth	-105.98%	3,346.47%	-100.90%	15,595.38%	-88.55%	59.58%	-326.75%	250.34%	-39.76%	112.91%
Invested Capital Q/Q Growth	-4.42%	-2.27%	5.11%	9.84%	-2.09%	5.10%	7.66%	-17.11%	6.91%	-1.99%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	79.94%	82.30%	79.78%	89.76%	83.86%	81.42%	83.26%	84.60%	83.31%	85.55%
EBITDA Margin	-18.41%	44.31%	2.68%	48.55%	28.35%	19.38%	14.71%	29.71%	29.69%	39.53%
Operating Margin	-24.03%	37.94%	-3.82%	45.56%	23.41%	14.47%	12.36%	27.53%	27.70%	37.84%
EBIT Margin	-26.18%	37.86%	-3.83%	45.47%	23.45%	14.47%	12.41%	28.04%	27.85%	37.94%
Profit (Net Income) Margin	-25.35%	-9.27%	-14.55%	38.40%	12.54%	29.88%	10.51%	22.89%	24.43%	34.07%
Tax Burden Percent	94.96%	-24.68%	369.23%	84.12%	51.52%	193.39%	78.50%	78.27%	83.81%	86.23%
Interest Burden Percent	101.99%	99.26%	102.92%	100.39%	103.77%	106.76%	107.87%	104.27%	104.67%	104.14%
Effective Tax Rate	0.00%	15.40%	0.00%	0.97%	1.24%	-175.31%	16.98%	18.90%	15.82%	14.22%
Return on Invested Capital (ROIC)	-31.29%	58.56%	-4.92%	102.89%	59.27%	105.14%	26.39%	52.76%	53.81%	76.33%
ROIC Less NNEP Spread (ROIC-NNEP)	-26.62%	85.45%	3.00%	110.57%	66.24%	112.77%	26.20%	52.41%	53.19%	75.29%
Return on Net Nonoperating Assets (RNNOA)	11.48%	-37.15%	-1.24%	-50.57%	-31.97%	-49.48%	-10.64%	-26.33%	-26.98%	-37.90%
Return on Equity (ROE)	-19.81%	21.41%	-6.16%	52.32%	27.31%	55.66%	15.75%	26.43%	26.83%	38.42%
Cash Return on Invested Capital (CROIC)	7.04%	10.20%	-4.72%	40.37%	63.06%	63.72%	63.35%	65.57%	55.55%	59.96%
Operating Return on Assets (OROA)	-15.05%	21.10%	-2.20%	32.08%	17.68%	11.74%	10.59%	19.25%	18.91%	28.20%
Return on Assets (ROA)	-14.57%	-5.17%	-8.36%	27.09%	9.45%	24.24%	8.97%	15.71%	16.58%	25.32%
Return on Common Equity (ROCE)	-19.81%	21.41%	-6.16%	52.32%	27.31%	55.66%	15.75%	26.43%	26.83%	38.42%
Return on Equity Simple (ROE_SIMPLE)	-12.38%	0.00%	-16.33%	8.04%	15.84%	0.00%	34.62%	22.49%	25.80%	0.00%
Net Operating Profit after Tax (NOPAT)	-42	98	-7.68	279	88	150	36	89	88	140
NOPAT Margin	-16.82%	32.10%	-2.67%	45.12%	23.12%	39.85%	10.26%	22.33%	23.32%	32.46%
Net Nonoperating Expense Percent (NNEP)	-4.67%	-26.89%	-7.91%	-7.68%	-6.97%	-7.64%	0.19%	0.35%	0.62%	1.03%
Return On Investment Capital (ROIC_SIMPLE)	-3.18%	7.31%	-0.59%	17.71%	5.35%	10.07%	2.33%	5.66%	5.58%	9.53%
Cost of Revenue to Revenue	20.06%	17.70%	20.22%	10.24%	16.14%	18.58%	16.74%	15.40%	16.69%	14.45%
SG&A Expenses to Revenue	60.54%	46.79%	58.36%	31.71%	41.05%	44.98%	51.30%	42.12%	39.77%	34.19%
R&D to Revenue	39.80%	-5.43%	22.17%	11.05%	17.03%	19.59%	19.30%	14.94%	15.84%	13.53%
Operating Expenses to Revenue	103.97%	44.36%	83.59%	44.20%	60.44%	66.95%	70.90%	57.07%	55.61%	47.72%
Earnings before Interest and Taxes (EBIT)	-66	115	-11	281	89	55	43	112	105	163
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-46	135	7.70	300	108	73	52	119	112	170
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.27	3.82	4.28	3.78	3.20	3.85	3.60	3.18	3.57	3.18
Price to Tangible Book Value (P/TBV)	3.78	4.32	4.87	4.14	3.46	4.14	3.86	3.40	3.81	3.37
Price to Revenue (P/Rev)	3.01	3.59	3.84	3.31	2.73	2.78	2.62	2.70	3.06	2.99
Price to Earnings (P/E)	0.00	0.00	0.00	45.58	19.58	12.73	10.29	13.94	13.56	12.64
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	2.19%	5.11%	7.85%	9.72%	7.17%	7.37%	7.91%
Enterprise Value to Invested Capital (EV/IC)	5.01	6.15	6.45	6.34	5.58	6.00	5.43	5.57	6.08	5.98
Enterprise Value to Revenue (EV/Rev)	2.61	3.19	3.49	2.89	2.28	2.47	2.32	2.26	2.64	2.46
Enterprise Value to EBITDA (EV/EBITDA)	43.81	67.97	46.60	10.65	6.60	8.40	7.51	9.69	11.16	8.46
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	601.88	13.22	7.66	9.93	8.54	11.37	12.59	9.03
Enterprise Value to NOPAT (EV/NOPAT)	546.16	0.00	0.00	13.73	8.02	8.05	7.19	9.35	10.90	10.85
Enterprise Value to Operating Cash Flow (EV/OCF)	57.95	168.43	0.00	21.51	12.31	10.23	9.01	9.10	11.15	8.72
Enterprise Value to Free Cash Flow (EV/FCFF)	69.07	57.04	0.00	16.30	9.28	10.22	9.40	8.14	10.96	9.64
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.28	0.28	0.29	0.23	0.21	0.24	0.23	0.23	0.22	0.00
Long-Term Debt to Equity	0.28	0.28	0.29	0.23	0.21	0.24	0.23	0.22	0.22	0.00
Financial Leverage	-0.43	-0.43	-0.41	-0.46	-0.48	-0.44	-0.41	-0.50	-0.51	-0.50
Leverage Ratio	1.84	1.85	1.87	1.75	1.76	1.83	1.79	1.71	1.67	1.57
Compound Leverage Factor	1.88	1.84	1.93	1.76	1.83	1.95	1.93	1.79	1.75	1.64
Debt to Total Capital	21.99%	21.93%	22.54%	18.57%	17.69%	19.47%	18.78%	18.40%	18.27%	0.00%
Short-Term Debt to Total Capital	0.22%	0.22%	0.23%	0.19%	0.18%	0.20%	0.19%	0.19%	0.19%	0.00%
Long-Term Debt to Total Capital	21.76%	21.71%	22.31%	18.38%	17.51%	19.27%	18.58%	18.21%	18.08%	0.00%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	78.01%	78.07%	77.46%	81.43%	82.31%	80.53%	81.22%	81.60%	81.73%	100.00%
Debt to EBITDA	4.36	5.62	3.49	0.74	0.53	0.60	0.54	0.82	0.81	0.00
Net Debt to EBITDA	-6.72	-8.57	-4.77	-1.55	-1.28	-1.07	-0.97	-1.92	-1.80	0.00
Long-Term Debt to EBITDA	4.31	5.57	3.45	0.73	0.52	0.59	0.54	0.82	0.80	0.00
Debt to NOPAT	54.30	-68.81	-8.38	0.95	0.64	0.57	0.52	0.80	0.79	0.00
Net Debt to NOPAT	-83.72	104.83	11.46	-2.00	-1.55	-1.02	-0.93	-1.85	-1.75	0.00
Long-Term Debt to NOPAT	53.74	-68.10	-8.30	0.94	0.64	0.56	0.52	0.79	0.79	0.00
Altman Z-Score	1.90	2.54	2.50	3.83	3.26	3.50	3.71	3.29	3.95	5.64
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.24	2.27	2.25	2.87	2.91	2.86	3.20	2.99	3.45	3.04
Quick Ratio	1.78	1.80	1.76	2.39	2.44	2.13	2.31	2.41	2.81	2.44
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-5.06	164	-1.49	230	26	42	-95	143	86	184
Operating Cash Flow to CapEx	5.97%	10.44%	-310.52%	2,223.36%	690.02%	642.83%	266.15%	2,060.24%	990.40%	1,949.59%
Free Cash Flow to Firm to Interest Expense	-1.42	34.43	-0.28	40.49	4.39	6.95	-15.96	24.10	14.40	39.58
Operating Cash Flow to Interest Expense	0.18	0.22	-4.03	37.95	16.60	17.71	3.53	24.53	13.60	40.96
Operating Cash Flow Less CapEx to Interest Expense	-2.77	-1.88	-5.33	36.24	14.20	14.96	2.20	23.34	12.23	38.86
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.57	0.56	0.57	0.71	0.75	0.81	0.85	0.69	0.68	0.74
Accounts Receivable Turnover	4.14	3.70	4.32	5.04	5.35	5.36	5.90	4.30	4.27	4.34
Inventory Turnover	1.43	1.31	1.30	1.31	1.32	1.38	1.32	1.31	1.32	1.33
Fixed Asset Turnover	3.39	3.94	3.41	4.42	4.87	7.40	6.33	5.52	5.44	6.85
Accounts Payable Turnover	0.68	1.02	1.22	1.05	1.04	1.10	1.28	1.04	1.26	1.15
Days Sales Outstanding (DSO)	88.11	98.68	84.53	72.44	68.25	68.07	61.85	84.83	85.47	84.01
Days Inventory Outstanding (DIO)	255.60	277.64	280.49	278.63	276.24	265.29	275.97	278.46	276.10	274.71
Days Payable Outstanding (DPO)	535.70	358.68	299.89	347.08	350.18	332.24	285.07	349.93	290.64	316.82
Cash Conversion Cycle (CCC)	-191.99	17.65	65.12	3.98	-5.69	1.12	52.75	13.35	70.93	41.90
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	590	576	606	665	651	685	737	611	653	640
Invested Capital Turnover	1.86	1.82	1.84	2.28	2.56	2.64	2.57	2.36	2.31	2.35
Increase / (Decrease) in Invested Capital	-37	-66	-6.20	48	62	108	131	-54	1.78	-44
Enterprise Value (EV)	2,956	3,544	3,908	4,218	3,633	4,107	4,000	3,405	3,970	3,829
Market Capitalization	3,410	3,991	4,308	4,834	4,337	4,629	4,517	4,078	4,609	4,653
Book Value per Share	$6.35	$6.35	$6.12	$7.70	$8.14	$7.21	$7.47	$7.59	$7.85	$9.05
Tangible Book Value per Share	$5.50	$5.62	$5.38	$7.02	$7.52	$6.70	$6.97	$7.09	$7.34	$8.54
Total Capital	1,337	1,337	1,298	1,572	1,647	1,493	1,545	1,573	1,581	1,465
Total Debt	294	293	293	292	291	291	290	289	289	0.00
Total Long-Term Debt	291	290	290	289	288	288	287	286	286	0.00
Net Debt	-453	-447	-400	-615	-704	-523	-518	-673	-639	-825
Capital Expenditures (CapEx)	10	10	6.86	9.70	14	17	7.93	7.09	8.24	9.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)	7.06	27	20	84	76	195	268	154	205	198
Debt-free Net Working Capital (DFNWC)	587	636	620	913	965	968	1,013	1,030	1,113	950
Net Working Capital (NWC)	584	633	617	910	962	965	1,010	1,027	1,110	950
Net Nonoperating Expense (NNE)	22	126	34	41	40	38	-0.87	-2.24	-4.19	-6.94
Net Nonoperating Obligations (NNO)	-453	-468	-400	-615	-704	-518	-518	-673	-639	-825
Total Depreciation and Amortization (D&A)	20	20	19	19	19	19	8.06	6.66	6.97	6.85
Debt-free, Cash-free Net Working Capital to Revenue	0.62%	2.44%	1.76%	5.75%	4.75%	11.71%	15.51%	10.18%	13.59%	12.74%
Debt-free Net Working Capital to Revenue	51.90%	57.17%	55.33%	62.46%	60.65%	58.21%	58.68%	68.28%	73.98%	61.00%
Net Working Capital to Revenue	51.63%	56.90%	55.06%	62.25%	60.46%	58.03%	58.50%	68.08%	73.78%	61.00%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.39)	($0.18)	($0.25)	$1.43	$0.29	$0.67	$0.22	$0.54	$0.57	$0.89
Adjusted Weighted Average Basic Shares Outstanding	164.28M	163.74M	165.09M	166.28M	166.61M	166.22M	167.98M	168.32M	163.37M	165.39M
Adjusted Diluted Earnings per Share	($0.39)	($0.18)	($0.25)	$1.38	$0.28	$0.69	$0.21	$0.53	$0.55	$0.88
Adjusted Weighted Average Diluted Shares Outstanding	164.28M	163.74M	165.09M	171.55M	171.90M	169.73M	172.98M	170.98M	167.03M	169.20M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	164.31M	164.39M	166.12M	166.56M	166.88M	167.08M	169.22M	164.67M	161.80M	162.61M
Normalized Net Operating Profit after Tax (NOPAT)	-42	98	-7.68	279	88	38	36	89	88	140
Normalized NOPAT Margin	-16.82%	32.10%	-2.67%	45.12%	23.12%	10.13%	10.26%	22.33%	23.32%	32.46%
Pre Tax Income Margin	-26.70%	37.58%	-3.94%	45.65%	24.34%	15.45%	13.39%	29.24%	29.15%	39.51%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-18.60	24.18	-2.08	49.39	14.88	9.02	7.28	18.81	17.55	35.10
NOPAT to Interest Expense	-11.95	20.51	-1.45	49.01	14.67	24.84	6.01	14.97	14.70	30.03
EBIT Less CapEx to Interest Expense	-21.55	22.08	-3.38	47.69	12.47	6.27	5.95	17.62	16.18	33.00
NOPAT Less CapEx to Interest Expense	-14.90	18.40	-2.75	47.30	12.26	22.09	4.69	13.78	13.32	27.92
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	29.33%	60.08%	54.56%

Frequently Asked Questions About Alkermes' Financials

When does Alkermes's financial year end?

According to the most recent income statement we have on file, Alkermes' fiscal year ends in December. Their fiscal year 2024 ended on December 31, 2024.

How has Alkermes' net income changed over the last 9 years?

Alkermes' net income appears to be on a downward trend, with a most recent value of $367.07 million in 2024, falling from -$227.16 million in 2015. The previous period was $355.76 million in 2023.

What is Alkermes's operating income?

Alkermes's total operating income in 2024 was $420.64 million, based on the following breakdown:

Total Gross Profit: $1.31 billion
Total Operating Expenses: $891.67 million

How has Alkermes revenue changed over the last 9 years?

Over the last 9 years, Alkermes' total revenue changed from $628.34 million in 2015 to $1.56 billion in 2024, a change of 147.9%.

How much debt does Alkermes have?

Alkermes' total liabilities were at $590.59 million at the end of 2024, a 36.7% decrease from 2023, and a 9.1% increase since 2015.

How much cash does Alkermes have?

In the past 9 years, Alkermes' cash and equivalents has ranged from $181.11 million in 2015 to $457.47 million in 2023, and is currently $291.15 million as of their latest financial filing in 2024.

How has Alkermes' book value per share changed over the last 9 years?

Over the last 9 years, Alkermes' book value per share changed from 8.76 in 2015 to 9.05 in 2024, a change of 3.4%.

Remove Ads

Related Companies

This page (NASDAQ:ALKS) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Alkermes (ALKS) Financials

Frequently Asked Questions About Alkermes' Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Alkermes (ALKS) Financials

Annual Income Statements for Alkermes

Quarterly Income Statements for Alkermes

Annual Cash Flow Statements for Alkermes

Quarterly Cash Flow Statements for Alkermes

Annual Balance Sheets for Alkermes

Quarterly Balance Sheets for Alkermes

Annual Metrics and Ratios for Alkermes

Quarterly Metrics and Ratios for Alkermes

Frequently Asked Questions About Alkermes' Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools